RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DELCURATOLO MD
Collezione ASL Asti

Items : 8

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.

2024
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Di Stefano RF; Farinea G; Fossati N; Gallina A; Zilli T; Vogl UM; Buttigliero C; Delcuratolo MD; Gillessen S; Turco F;

Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma. in Journal of clinical medicine / J Clin Med. 2024 Jan 5;13(2):307. doi: 10.3390/jcm13020307.

2024
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Carfì FM; Calabrese M; Saporita I; Pisano C; Delcuratolo MD; Turco F; Di Stefano RF; Samuelly A; Buttigliero C;

Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis. in Cells / Cells. 2024 Aug 22;13(16):1396. doi: 10.3390/cells13161396.

2024
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Di Stefano FR; Audisio M; Turco F; Delcuratolo MD; Poletto S; Saporita I; Carfì F; Calabrese M; Farinea G; Buttigliero C;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Brusa F; Audisio A; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Turco F; Tucci M; Delcuratolo MD;

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? in Cells / Cells. 2022 May 11;11(10):1614. doi: 10.3390/cells11101614.

2022
ASL Asti

Audisio M; Buttigliero C; Turco F; Delcuratolo MD; Pisano C; Parlagreco E; Di Stefano RF; Di Prima L; Crespi V; Farinea G; Cani M; Tucci M;

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond. in Cells / Cells. 2022 Jan 21;11(3):357. doi: 10.3390/cells11030357.

2022
ASL Asti
AOU San Luigi di Orbassano

Di Prima L; Di Stefano RF; Ungaro A; Audisio M; Parlagreco E; Delcuratolo MD; Buttigliero C; Audisio A; Turco F; Tucci M;

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Delcuratolo MD; Turco F; Di Prima L; Pisano C; Audisio A; Tucci M; Ungaro A;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Ortega C; Ungaro A; Audisio M; Pisano C; Audisio A; Di Stefano RF; Tucci M; Delcuratolo MD; Turco F;